HOME >> BIOLOGY >> NEWS
Unique global light source Website launched

The international light source community has launched the first website dedicated to providing the media, general public and scientific community with the latest news and information on the world's accelerator-driven light sources (synchrotrons and free-electron lasers) and the science they produce.

The web site -- www.lightsources.org -- was developed and is jointly maintained by the Light Source Communicators Group, whose members represent the world's light source facilities in Europe, North America and Asia. Funding for the project is provided by science funding agencies of many nations.

Accelerator-driven light sources can be large, roughly circular machines or linear machines (usually about the size of a football field to much larger) that accelerate electrons to almost the speed of light. It acts like a gigantic microscope that generates intense beams of brilliant light to view the microstructure of materials.

Light sources around the world are advancing research and development in fields as diverse as medicine, drug design, environmental science, agriculture, minerals explorations, advanced materials, forensics, engineering, and materials fabrication.

Visit www.lightsources.org for the latest news releases on cutting-edge areas of advanced light source applications for science and technology from facilities around the world.

Anyone can subscribe free of charge to "News Flash" which will email subscribers when news releases and other light source information is posted to the website. Also available on the website are an image bank of light source-related photos and graphics, clippings of news stories, links to light source facility websites, and relevant articles and presentations.

Educators will find links to websites relating to light sources and the science conducted at these facilities. Researchers can find specific information regarding each light source fac
'"/>

Contact: Amaya Munoz
webmaster@lightsources.org
DOE/Thomas Jefferson National Accelerator Facility
4-Mar-2005


Page: 1 2

Related biology news :

1. Unique tomatoes tops in disease-fighting antioxidants
2. Unique estrogen receptor linked to metastatic breast cancer
3. Unique imaging uncovers the invisible world where surfaces meet
4. Unique gene regulation gives chilly bugs survival advantage at bottom of the world
5. Unique Huntingtons study moves forward
6. Unique dual target specificity of kinase inhibitor key for success against cancer
7. Unique soybean lines hold promise for producing allergy-free soybeans
8. Uniquely human component of language found in gregarious birds
9. Unique equine cataract surgery offered on routine basis
10. Unique interplay between tumor and blood vessel cells promotes angiogenesis and tumor growth
11. Unique genetic profile helps over-45s conceive naturally

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Unique global light source Website launched

(Date:5/22/2013)... YORK, May 22, 2013. Plastic additives known as ... about everywhere: They turn up in flooring, plastic ... to the Centers for Disease Control and Preventionthe ... phthalates have come under increasing scrutiny. A growing ... (which can leech from packaging and mix with ...
(Date:5/21/2013)... infections occur in the body, stem cells in ... and differentiating into mature immune cells that can ... can deplete these cell populations, potentially leading to ... cancer. Now, a team of researchers led by ... has found that, in mouse models, the molecule ...
(Date:5/21/2013)... Widely available in pharmacies and health stores, phosphatidylserine ... oysters, and soy. Proven to improve cognition and ... older people experiencing memory impairment. Now a team ... Bochner of Tel Aviv University,s Department of ... same supplement improves the functioning of genes involved ...
Breaking Biology News(10 mins):Study links chemicals widely found in plastics and processed food to elevated blood pressure in children and teens 2Keeping stem cells strong 2Common food supplement fights degenerative brain disorders 2
(Date:5/21/2013)... (PRWEB) May 21, 2013 ... services company for clinical trials, announced today it ... Solutions, LLC. Clinverse’s ClinPay® FLS eClinical commerce ... payment process. SpendMD ™, Aggregate Spend ... solution for tracking and reporting transfer of value ...
(Date:5/21/2013)... May 21, 2013 According to ... ( http://www.transparencymarketresearch.com ) "Biochip Products and Services Market (Microarrays, ... Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018," the ... and is expected to grow at a CAGR of ... value of USD 4.7 billion in 2018. ...
(Date:5/21/2013)... May 21, 2013 Many have long ... contributor to acne. Recently physicians from Clinical Psychiatry.com ... stress on the skin, and suggested using hypnotherapy ... the chemicals produced from stress that cause acne. , ... negative feelings acne brings about, stress causes changes in ...
(Date:5/21/2013)... , May 21, 2013  MacroGenics, Inc. ... study of margetuximab (MGAH22), an Fc-modified chimeric monoclonal ... expressing the HER2 oncoprotein," will be presented at ... of Clinical Oncology during the Developmental Therapeutics - ... at 4:15 – 4:30 PM.  The presentation will ...
Breaking Biology Technology:Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 3The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 2The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 3The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 4The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 5Adult Acne Treatment, Probiotic Action Explains How Hypnotherapy and Probiotics May Cure Various Skin Conditions 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3
Cached News: